Treatment for women with postpartum iron deficiency anaemia

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 8, 2015, Pages

  Markova, Veronika ^a   Norgaard, Astrid ^a   Jørgensen, Karsten Juhl ^b   Langhoff Roos, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FOLIC ACID; HEMOGLOBIN; IRON; PLACEBO;

ALLERGIC REACTION; CARDIOMYOPATHY; DRUG FATALITY; ERYTHROCYTE TRANSFUSION; FATIGUE; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; META ANALYSIS (TOPIC); POSTPARTUM IRON DEFICIENCY ANEMIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADULT; ANEMIA, IRON-DEFICIENCY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; ORAL DRUG ADMINISTRATION; PUERPERAL DISORDERS; PUERPERIUM;

ADMINISTRATION, ORAL; ADULT; ANEMIA, IRON-DEFICIENCY; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; FATIGUE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; IRON; POSTPARTUM PERIOD; PUERPERAL DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84991199768     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010861.pub2     Document Type: Review

References (125)

1. Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. Journal of Nutrition 2005;135(2):267-72.
2. Murray-Kolb LE, Beard JL. Iron deficiency and child and maternal health. American Journal of Clinical Nutrition 2009;89(3):946S-950S.
3. Perez EM, Hendricks MK, Beard JL, Murray-Kolb LE, Berg A, Tomlinson M, et al. Mother-infant interactions and infant development are altered by maternal iron deficiency anemia. Journal of Nutrition 2005;135(4):850-5.
4. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG: an International Journal of Obstetrics and Gynaecology 2006;113(11):1248-52.
5. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. International Journal of Obstetric Anesthesia 2004;13(3):S7.
6. Breymann C, Zimmermann R, Huch R, Huch A. Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia. European Journal of Clinical Investigation 1996;26(2):123-30.
7. Krafft A, Breymann C, Huttner C, Huch R, Huch A. Erythropoietic quality of maternal milk. Lancet 1999;354(9180):778.
8. Breymann C, Richter C, Huttner C, Huch R, Huch A. Effectiveness of recombinant erythropoietin and iron sucrose vs Iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. European Journal of Clinical Investigation 2000;30(2):154-61.
9. Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. International Journal of Gynecology & Obstetrics 2008;101(1):67-73.
10. Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. Journal of Maternal-Fetal & Neonatal Medicine 2013;26(7):654-9.
11. Guerra S, Lopez A, Munoz H, Marin JM, Lete I, Aizpuru F. Randomized clinical trial to evaluate the effectiveness of two routes of iron administration, oral and intravenous, in the treatment of postpartum iron deficiency anemia [Spanish] [Ensayo clinico aleatorizado para evaluar la efectividad de dos vias de administracion de hierro, oral e intravenosa, en el tratamiento de la anemia ferropenica posparto]. Clinica e Investigacion en Ginecologia y Obstetricia 2012;39(5):190-5.
12. Jain G, Palaria U, Jha SK. Intravenous iron in postpartum anemia. Journal of Obstetrics and Gynecology of India 2013;63(1):45-8.
13. Krafft A, Breymann C. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study. Journal of Obstetrics and Gynaecology Research 2011;37(2):119-24.
14. Krauss V, Nowotny D, Scharifzadeh AH. Effect and tolerance of oral iron therapy in the puerperium. Munchener Medizinische Wochenschrift 1972;114(43):1877-9.
15. Lebrecht A, Haberlin F, Eberhard J. Postpartum anaemia: Intravenous iron supplementation renders therapy with rHuEPO redundant [Anamie im Wochenbett; parenterale Eisensubstitution macht Erythropoetin-Therapie entbehrlich]. Geburtshilfe und Frauenheilkunde 1995;55(3):167-70.
16. Makrydimas G, Lolis D, Lialios G, Tsiara S, Georgiou I, Bourantas KL. Recombinant human erythropoietin treatment of postpartum anemia Preliminary results. European Journal of Obstetrics & Gynecology and Reproductive Biology 1998;81(1):27-31.
17. Meyer JW, Eichhorn KH, Vetter K, Christen S, Schleusner E, Klos A, et al. Does recombinant human erythropoietin not only treat anemia but reduce postpartum (emotional) distress as well?. Journal of Perinatal Medicine 1995;23:99-109.
18. Mumtaz A, Farooq F. Comparison for effects of intravenous versus oral iron therapy for postpartum anemia. Pakistan Journal of Medical and Health Sciences 2011;5(1):116-20.
19. Palacio M. Intravenous iron versus oral iron for severe postpartum anemia randomized trial. ClinicalTrials.gov (accessed 5 June 2012) 2007.
20. Perello MF, Coloma JL, Masoller N, Esteve J, Palacio M. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. BJOG: an International Journal of Obstetrics & Gynaecology 2014;121(6):706-14.
21. Jansen AJG, Duvekot JJ, Essink-Bot ML, Hop WCJ, Van Rhenen DJ. Multicentre clinical study into the optimal blood transfusion policy in patients with postpartum haemorrhage: The 'Wellbeing of obstetric patients on minimal blood transfusions' (WOMB) study [Een klinisch multicentrisch onderzoek naar het optimale bloedtransfusiebeleid bij patienten met een fluxus post partum: De 'Wellbeing of obstetric patients on minimal blood transfusions'(WOMB)-studie]. Nederlands Tijdschrift voor Geneeskunde 2007;151(39):2170-2.
22. Prick B, Jansen A, Steegers E, Hop W, Essink-Bot M, Uyl-de Groot C, et al. Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG: an International Journal of Obstetrics and Gynaecology 2014;121(8):1005-14.
23. Prick BW, Duvekot JJ, van der Moer PE, van Gemund N, van der Salm PC, Jansen AJ, et al. Cost-effectiveness of red blood cell transfusion vs. non-intervention in women with acute anaemia after postpartum haemorrhage. Vox Sanguinis 2014;107(4):381-8.
24. Prick BW, Jansen AJG, Steegers EAP, Hop WCJ, Essink-Bot ML, Uyl-de Groot CA, et al. RBC transfusion leads to an improvement of physical fatigue in women with acute postpartum anemia: the WOMB study (NCT00335023). American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S41-2.
25. Prick BW, Jansen AJG, Steegers EAP, Hop WCJ, Essink-Bot ML, de Uyl-Groot CA, et al. Health related quality of life in patients with acute anemia after primary postpartum hemorrhage: A randomized controlled trial of red blood cell transfusion vs expectant management: The womb study. Vox Sanguinis 2012;103(Suppl 1):35.
26. Prick BW, Steegers EAP, Jansen AG, Hop WCJ, Essink-Bot M-L, Peters NCJ, et al. Well being of obstetric patients on minimal blood transfusions (WOMB trial). BMC Pregnancy and Childbirth 2010;10:83.
27. Van Rhenen DJ. Wellbeing of obstetric patients on minimal bloodtranfusions study -WOMB study. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005)) 2005.
28. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology 2008;199(4):435.e-1-435.e7.
29. Seid MH, Rogers R, Dinh Q. Treating postpartum anemia with intravenous ferric carboxymaltose in a randomized controlled study. American Journal of Obstetrics and Gynecology 2007;197(6 Suppl 1):S26, Abstract no: 55.
30. Tam KF, Lee CP, Pun TC. Mild postnatal anemia: is it a problem?. American Journal of Perinatology 2005;22(7):345-9.
31. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstetrics & Gynecology 2007;110(2 Pt 1):267-78.
32. Verma S, Inamdar SA, Malhotra N. Intravenous iron therapy versus oral iron in postpartum patients in rural area. Journal of SAFOG 2011;3(2):67-70.
33. Wagstrom E, Akesson A, Van Rooijen M, Larson B, Bremme K. Erythropoietin and intravenous iron therapy in postpartum anaemia. Acta Obstetricia et Gynecologica Scandinavica 2007;86(8):957-62.
34. Westad S, Backe B, Salvesen K, Nakling J, Okland I, Borthen I, et al. A 12-week randomised, multi-centre study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anaemia. International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S377.
35. Westad S, Backe B, Salvesen KA, Nakling J, Okland I, Borthen I, et al. A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstetricia et Gynecologica Scandinavica 2008;87(9):916-23.
36. Breymann C, von Seefried B, Stahel M, Geisser P, Canclini C. Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. Journal of Perinatal Medicine 2007;35(2):115-8.
37. Casparis D, Del Carlo P, Branconi F, Grossi A, Merante D, Gafforio L. Effectiveness and tolerance of oral doses of liquid ferrous gluconate in iron-deficiency anaemia during pregnancy and in the immediate post-natal period: comparison with other liquid or solid formulations containing bivalent or trivalent iron. Minerva Ginecologica 1996;48:511-8.
38. Daniilidis A, Giannoulis C, Pantelis A, Tantanasis T, Dinas K. Total infusion of low molecular weight iron-dextran for treating postpartum anemia. Clinical and Experimental Obstetrics and Gynecology 2011;38(2):159-61.
39. Danko J, Huch R, Huch A. Epoetin alfa for treatment of postpartum anaemia. Lancet 1990;335(8691):737-8.
40. Dede A, Uygur D, Yilmaz B, Mungan T, Ugur M. Intravenous iron sucrose complex vs. oral ferrous sulfate for postpartum iron deficiency anemia. International Journal of Gynecology & Obstetrics 2005;90(3):238-9.
41. Giannoulis C. Intravenous administration of iron sucrose for treating anemia in postpartum women. Hippokratia 2009;13(1):38-40.
42. Haidar J, Umeta M, Kogi-Makau W. Effect of iron supplementation on serum zinc status of lactating women in Addis Ababa, Ethiopia. East African Medical Journal 2005;82(7):349-52.
43. Hashmi Z, Bashir G, Azeem P, Shah S. Effectiveness of intra-venous iron sucrose complex versus intra-muscular iron sorbitol in iron deficiency anemia. Annals of Pakistan Institute of Medical Sciences 2006;2(3):188-91.
44. Huch A, Eichhorn KH, Danko J, Lauener PA, Huch R. Recombinant human erythropoietin in the treatment of postpartum anemia. Obstetrics & Gynecology 1992;80(1):127-31.
45. Huch A, Huch R. EPO (rHuEPO) use in obstetrics. Proceedings of Ross Laboratories Special Conference, Hot Topics '90 in Neonatology; 1990 Dec 9-11; Washington DC, USA. 1990:79-80.
46. Mara M, Eretova V, Zivny J, Kvasnicka J, Umlaufova A, Marova E. Anemia and its treatment with peroral anti-anemia agents in women during the postpartum period. [Czech]. Ceska Gynekologie 1999;64:153-8.
47. Mara M, Zivny J, Eretova V, Kvasnicka J, Kuzel D, Umlaufova A, et al. Changes in markers of anemia and iron metabolism and how they are influenced in the postpartum period. Acta Obstetricia et Gynecologica Scandinavica 2001;80:142-8.
48. Mitra AK, Khoury AJ. Universal iron supplementation: a simple and effective strategy to reduce anaemia among low-income, postpartum women. Public Health Nutrition 2012;15(3):546-53.
49. Osmond TG. Post-partum anaemia -a practical treatment. Practitioner 1953;171:77-80.
50. Picha E. Iron treatment by effervescent tablets. Geburtshilfe und Frauenheilkunde 1975;35(10):792-5.
51. Van Der Woude DAA, De Vries J, Van Wijk EM, Verzijl JM, Pijnenborg JMA. A randomized controlled trial examining the addition of folic acid to iron supplementation in the treatment of postpartum anemia. International Journal of Gynaecology and Obstetrics 2014;126:101-5.
52. Van der Woude D. Iron and folic acid v.s. iron solely in the treatment of post partum anaemia; effects on haemoglobin and health status. Netherlands Trial Register (http://www.trialregister.nl) (accessed 8 July 2011) 2011.
53. Zimmermann R, Breymann C, Huch R, Huch A. rHuEPO in the treatment of postpartum anemia: subcutaneous versus intravenous administration. Clinical Investigator 1994;72(6 Suppl):S25-30.
54. Zimmermann R, Breymann C, Richter C, Huch R, Huch A. rhEPO treatment of postpartum anemia. Journal of Perinatal Medicine 1995;23:111-7.
55. Backe B. A 6-week randomised, open comparative, multi-centre study of intravenous ferric carboxymaltose (ferinject) and oral iron (duroferon) for treatment of post partum anemia. http://clinicaltrials.gov/ct2/show/record/NCT00929409 [accessed 5 June 2012] 2009.
56. Chaudhuri P. Intravenous iron-sucrose complex versus oral iron in the treatment of postpartum anemia. Clinical Trials Registry -India [accessed 12 November 2013] 2013.
57. EUCTR2012-005783-10-DK. A randomized comparative, open-label study of intravenous iron isomaltoside 1000 (Monofer®) administered by high single dose in-fusions or red blood cell transfusion in women with severe postpartum iron deficiency anaemia. EU Clinical Trials Register [accessed 13 November 2013] 2012.
58. Holm C, Thomsen LL, Norgaard A, Langhoff-Roos J. Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial. Trials 2015;16(1):5.
59. Hossain N. Use of iron isomaltoside 1000 (Monofer) in postpartum anemia. ClinicalTrials.gov [accessed 12 November 2013] 2013.
60. Suneja A. A clinical trial to compare oral iron ferrous sulfate with newer intravenous iron (ferric carboxymaltose) injection in patients of iron deficiency anemia in post delivery period. Clinical Trials Registry -India (http://ctri.nic.in) [accessed 14 October 2014] 2014.
61. al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1996;69(2):121-4.
62. Almeida LC, Cardoso MA. Recommendations for folate intake in women: implications for public health strategies. Cadernos de Saude Publica 2010;26(11):2011-26. [PUBMED: 21180975]
63. Auerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion 2008;48(5):988-1000.
64. Barish CF, Koch T, Butcher A, Morris D, Bregman DB. Safety and efficacy of intravenous ferric carboxymaltose (750 mg) in the treatment of iron deficiency anemia: two randomized, controlled trials. Anemia 2012;2012:172104.
65. Barroso F, Allard S, Kahan BC, Connolly C, Smethurst H, Choo L, et al. Prevalence of maternal anaemia and its predictors: a multi-centre study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2011;159(1):99-105.
66. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 2010;303(12):1180-7. [PUBMED: 20332404]
67. Bergmann RL, Richter R, Bergmann KE, Dudenhausen JW. Prevalence and risk factors for early postpartum anemia. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2010;150(2):126-31.
68. Bodnar LM, Cogswell ME, Scanlon KS. Low income postpartum women are at risk of iron deficiency. Journal of Nutrition 2002;132(8):2298-302.
69. Bodnar LM, Cogswell ME, McDonald T. Have we forgotten the significance of postpartum iron deficiency?. American Journal of Obstetrics and Gynecology 2005;193(1):36-44.
70. Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Archives of Gynecology and Obstetrics 2010;282(5):577-80.
71. Bunn HF. End run around epo. New England Journal of Medicine 2009; Vol. 361, issue 19:1901-3.
72. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD002042.pub3]
73. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. Journal of Psychosomatic Research 1993;37(2):147-53. [PUBMED: 8463991]
74. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. Journal of Health and Social Behavior 1983;24(4):385-96. [PUBMED: 6668417]
75. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 1987;150(6):782-6. [PUBMED: 3651732]
76. Dudrick SJ, O'Donnell JJ, Matheny RG, Unkel SP, Raleigh DP. Stimulation of hematopoiesis as an alternative to transfusion. Southern Medical Journal 1986;79(6):669-73.
77. European Medicines Agency. Assessment report for: Iron containing intravenous (IV) medicinal products. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/IV_iron_31/WC500150771.pdf 2013.
78. European Medicines Agency. New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/IV_iron_31/WC500151308.pdf 2013.
79. Fuller AJ, Bucklin BA. Blood product replacement for postpartum hemorrhage. Clinical Obstetrics and Gynecology 2010;53(1):196-208.
80. McMaster University. GRADEpro. [Computer program on www.gradepro.org]. 2014. McMaster University, 2014.
81. Gupta SD, Khanna A, Gupta R, Sharma NK, Sharma ND. Maternal mortality ratio and predictors of maternal deaths in selected desert districts in Rajasthan a community-based survey and case control study. Womens Health Issues 2010;20(1):80-5.
82. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesthesia and Analgesia 2009;108(3):759-69.
83. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
84. Hoyer WJ, Stawski RS, Wasylyshyn C, Verhaeghen P. Adult age and digit symbol substitution performance: a meta-analysis. Psychology and Aging 2004;19(1):211-4. [PUBMED: 15065945]
85. Hróbjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD003974.pub3]
86. Kennerley H, Gath D. Maternity blues. I. Detection and measurement by questionnaire. British Journal of Psychiatry 1989;155:356-62.
87. Khalafallah AA, Dennis AE. Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy. Journal of Pregnancy 2012;2012:630519.
88. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367(9516):1066-74.
89. Klein HG, Anstee DJ. Mollison's Blood Transfusion in Clinical Medicine. 12th Edition. ISBN:978-1-4051-9940-7, Wiley, 2014.
90. Kliger AS, Fishbane S, Finkelstein FO. Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment. Clinical Journal of the American Society of Nephrology: CJASN 2012;7(2):354-7.
91. Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. Journal of Obstetrics and Gynaecology Research 2013;39(2):504-10.
92. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ (Clinical research ed.) 2013;347:f4822. [PUBMED: 23950195]
93. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). British Journal of Clinical Psychology / the British Psychological Society 1992;31 ( Pt 3):301-6. [PUBMED: 1393159]
94. Milman N. Postpartum anemia I: definition, prevalence, causes, and consequences. Annals of Hematology 2011;90(11):1247-53.
95. Milman N. Anemia--still a major health problem in many parts of the world!. Annals of Hematology 2011;90(4):369-77. [PUBMED: 21221586]
96. Milman N. Postpartum anemia II: prevention and treatment. Annals of Hematology 2012;91(2):143-54.
97. Montufar-Rueda C, Rodriguez L, Jarquin JD, Barboza A, Bustillo MC, Marin F, et al. Severe postpartum hemorrhage from uterine atony: a multicentric study. Journal of pregnancy 2013;2013:525914. [PUBMED: 24363935]
98. Oster HS, Neumann D, Hoffman M, Mittelman M. Erythropoietin: the swinging pendulum. Leukemia Research 2012;36(8):939-44.
99. Parker JA, Barroso F, Stanworth SJ, Spiby H, Hopewell S, Doree CJ, et al. Gaps in the evidence for prevention and treatment of maternal anaemia: a review of systematic reviews. BMC Pregnancy and Childbirth 2012;12:56. [PUBMED: 22727258]
100. Pena-Rosas JP, De-Regil LM, Dowswell T, Viteri FE. Daily oral iron supplementation during pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD004736.pub4]
101. Portenoy RK. Fatigue measurement. Fatigue measurement. In: Max MB, Lynn J, editors. Interactive textbook of symptom research. Bethesda (MD): National Institutes of Health. Available at: http://painconsortium.nih.gov/symptomresearch/chapter_9/sec6/crps6pg1.htm. Accessed August 2013.
102. Reveiz L, Gyte GML, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD003094.pub3]
103. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
104. Richter C, Huch A, Huch R. Erythropoiesis in the postpartum period. Journal of Perinatal Medicine 1995;23(1-2):51-9.
105. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014;311(13):1317-26. [PUBMED: 24691607]
106. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. American Journal of Medicine 2014;127(2):124.e3-131.e3. [PUBMED: 24331453]
107. Schmitz N, Kruse J, Heckrath C, Alberti L, Tress W. Diagnosing mental disorders in primary care: the General Health Questionnaire (GHQ) and the Symptom Check List (SCL-90-R) as screening instruments. Social Psychiatry and Psychiatric Epidemiology 1999;34(7):360-6.
108. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50(4):753-65.
109. SHOT Steering Group. Annual SHOT report 2011. http://www.shotuk.org/wp-content/uploads/2012/07/SHOT-ANNUAL-REPORT_FinalWebVersionBookmarked_2012_06_22.pdf (accessed September 2013) 2011.
110. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research 1995;39(3):315-25. [PUBMED: 7636775]
111. Smith HM, Shirey RS, Thoman SK, Jackson JB. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility. Immunohematology 2013;29(4):127-30. [PUBMED: 24689681]
112. Toblli JE, Cao G, Olivieri L, Angerosa M. Comparative study of gastrointestinal tract and liver toxicity of ferrous sulfate, iron amino chelate and iron polymaltose complex in normal rats. Pharmacology 2008;82(2):127-37. [PUBMED: 18607114]
113. Toblli JE, Cao G, Oliveri L, Angerosa M. Effects of iron polymaltose complex, ferrous fumarate and ferrous sulfate treatments in anemic pregnant rats, their fetuses and placentas. Inflammation & Allergy Drug Targets 2013;12(3):190-8. [PUBMED: 23547731]
114. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. New England Journal of Medicine 2013;368(1):11-21.
115. Ware JE Jr. SF-36 health survey update. Spine 2000;25(24):3130-9.
116. Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998;279(3):217-21. [PUBMED: 9438742]
117. World Health Organization. Reduction of Maternal Mortality. A jointWHO/UNFPA/UNICEF/World Bank statement. Geneva: WHO, 1999.
118. World Health Organization. Iron Deficiency Anaemia -Assessment, Prevention, and Control WHO/NHD/01.3 2001. Geneva: WHO, 2001.
119. Rastogi T, Mathers C. Global burden of Iron Deficiency Anaemia in the year 2000. http://www.who.int/healthinfo/statistics/bod_irondeficiencyanaemia.pdf (accessed August 4 2013) 2002.
120. World Health Organization. Trends in maternal mortality: 1990 to 2010. WHO, UNICEF, UNFPA and The World Bank estimates. http://www.unfpa.org/webdav/site/global/shared/documents/publications/2012/Trends_in_maternal_mortality_A4-1.pdf (accessed September 2013) 2012.
121. World Health Organization. The WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: ICD-MM. http://apps.who.int/iris/bitstream/10665/70929/1/9789241548458_eng.pdf (accessed August 4 2013) 2012.
122. World Health Organization. International Classification of Diseases (ICD-10). http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf (accessed August 4 2013).
123. Wiesen AR, Hospenthal DR, Byrd JC, Glass KL, Howard RS, Diehl LF. Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleeding. Annals of Internal Medicine 1994;121(4):278-30.
124. Wysowski DK, Swartz L, Borders-Hemphill BV, Goulding MR, Dormitzer C. Use of parenteral iron products and serious anaphylactic-type reactions. American Journal of Hematology 2010;85(9):650-4.
125. Dodd J, Dare MR, Middleton P. Treatment for women with postpartum iron deficiency anaemia. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD004222.pub2]